Cancer

• A population-based survey to assess the association between cannabis and quality of life among colorectal cancer survivors (24 Sep 2024)
  
• Effects of standardized Cannabis sativa extract and ionizing radiation in melanoma cells in vitro (16 Sep 2024)
  
• Cannabinoids as an Alternative Option for Conventional Analgesics in Cancer Pain Management: A Pharmacogenomics Perspective (16 Sep 2024)
  
• Cannabinoids and triple-negative breast cancer treatment (03 Sep 2024)
  
• Morphine Analgesia, Cannabinoid Receptor 2, and Opioid Growth Factor Receptor Cancer Tissue Expression Improve Survival after Pancreatic Cancer Surgery (02 Sep 2024)
  
• Heterogeneity in hormone-dependent breast cancer and therapy: Steroid hormones, HER2, melanoma antigens, and cannabinoid receptors (02 Sep 2024)
  
• Overexpression of cannabinoid receptor 2 is associated with human breast cancer proliferation, apoptosis, chemosensitivity and prognosis via the PI3K/Akt/mTOR signaling pathway (30 Aug 2024)
  
• The Anti-Tumorigenic Role of Cannabinoid Receptor 2 in Colon Cancer: A Study in Mice and Humans (29 Aug 2024)
  
• Cannabinoid compounds in combination with curcumin and piperine display an anti-tumorigenic effect against colon cancer cells (29 Aug 2024)
  
• Cannabinoid Conference 2022 (27 Aug 2024)
  
• Cannabinoid Receptor-1 suppresses M2 macrophage polarization in colorectal cancer by downregulating EGFR (25 Aug 2024)
  
• Interplay between the Cannabinoid System and microRNAs in Cancer (21 Aug 2024)
  
• Impact of Cannabinoid Compounds on Skin Cancer (21 Aug 2024)
  
• Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma (20 Aug 2024)
  
• Cannabinoid Drugs-Related Neuroprotection as a Potential Therapeutic Tool Against Chemotherapy-Induced Cognitive Impairment (20 Aug 2024)
  
• Cannabidiol oxidation product HU-331 is a potential anticancer cannabinoid-quinone: a narrative review (20 Aug 2024)
  
• Down-Regulation of Cannabinoid Type 1 (CB1) Receptor and its Downstream Signaling Pathways in Metastatic Colorectal Cancer (19 Aug 2024)
  
• Antitumor Cannabinoid Chemotypes: Structural Insights (19 Aug 2024)
  
• Modulation of breast cancer cell viability by a cannabinoid receptor 2 (18 Aug 2024)
  
• Inflammation and cancer: friend or foe? (24 May 2024)
  
• Cannabis and cancer: unveiling the potential of a green ally in breast, colorectal, and prostate cancer (24 May 2024)
  
• Beyond Pain Relief: A Review on Cannabidiol Potential in Medical Therapies (27 Feb 2023)
  
• The Endocannabinoid System as a Pharmacological Target for New Cancer Therapies (05 Sep 2022)
  
• Self-Assembly System Based on Cyclodextrin for Targeted Delivery of Cannabidiol (05 Sep 2022)
  
• Cannabidiol Induces Cell Death in Human Lung Cancer Cells and Cancer Stem Cells (05 Sep 2022)
  
• The strengths and limits of cannabinoids and their receptors in cancer: Insights into the role of tumorigenesis-underlying mechanisms and therapeutic aspects (27 Aug 2022)
  
• Components of the Endocannabinoid System and Effects of Cannabinoids Against Bone Diseases: A Mini-Review (13 Aug 2022)
  
• Targeting the Endocannabinoidome in Pancreatic Cancer (05 Aug 2022)
  
• Medical Cannabis in Pediatric Oncology: Friend or Foe? (05 Aug 2022)
  
• Cannabinoids, their cellular receptors, and effects on the invasive phenotype of carcinoma and metastasis (05 Aug 2022)
  
• Mechanisms of Cannabidiol (CBD) in Cancer Treatment: A Review (31 Jul 2022)
  
• In Vitro Effect of Δ9-Tetrahydrocannabinol and Cannabidiol on Cancer-Associated Fibroblasts Isolated from Lung Cancer (31 Jul 2022)
  
• Effect of combining CBD with standard breast cancer therapeutics (31 Jul 2022)
  
• Cannabidiol oxidation product HU-331 is a potential anticancer cannabinoid-quinone: a narrative review - Journal of Cannabis Research (26 Jul 2022)
  
• Anti-cancer properties of cannflavin A and potential synergistic effects with gemcitabine, cisplatin, and cannabinoids in bladder cancer - Journal of Cannabis Research (26 Jul 2022)
  
• Combination of cannabidiol with low‑dose naltrexone increases the anticancer action of chemotherapy in vitro and in vivo (25 Jul 2022)
  
• ICRS 2019: CBD for Anxiety, Cancer, Heart Disease, Addiction... (21 Jul 2022)
  
• Encouraging Cancer Research (21 Jul 2022)
  
• Cannabis and Cannabinoids (PDQ®)–Patient Version (21 Jul 2022)
  
• Daily use of cannabidiol (‘CBD’) oil may be linked to lung cancer regression (18 Jul 2022)
  
• Customized Phytocannabinoid Profiles: A Novel Source of Precision Therapeutics for Specific Cancer Subtypes? (18 Jul 2022)
  
• CBD shows promise for fighting aggressive brain cancer (18 Jul 2022)